Skip to content

LifeMD, Inc. LFMD Free cash flow

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Spok Holdings logo
Spok HoldingsSPOK
$1.84M+21.9%
Teladoc Health logo
Teladoc HealthTDOC
$7.86M-40.5%
LifeStance Health Group logo
LifeStance Health GroupLFST
$22.34M+318%
DocGo logo
DocGoDCGO
-$5.09M-162%
Hims & Hers Health logo
Hims & Hers HealthHIMS

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Calculated from LifeMD, Inc.’s reported figures.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s free cash flow?
LifeMD, Inc. (LFMD) reported free cash flow of $339.45K in Q1 2026.
How has LifeMD, Inc.'s free cash flow changed year-over-year?
LifeMD, Inc.'s free cash flow decreased by 88.5% year-over-year, from $2.95M to $339.45K.
What is the long-term trend for LifeMD, Inc.'s free cash flow?
Over 2 years (2022 to 2024), LifeMD, Inc.'s free cash flow has grown at a -17.0% compound annual growth rate (CAGR), from -$23.3M to $16.05M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.